ABUS
Arbutus Biopharm (ABUS)
NASDAQ
$5.25+$0.04 (+0.77%)
Price as of Aug 21, 2026 7:59 PM EDT
  • $1.0B
    Market Cap
  • 45.13%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 78
Valuation
ABUS
vs History
vs S&P 500
Profitability
0
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 75
Valuation
ABUS
vs History
vs S&P 500
3-Month Momentum
6.43%
12-Month Momentum
24.86%
3-Month Risk Adjusted Momentum
34.47%
12-Month Risk Adjusted Momentum
53.57%

True Yield

N/A
Valuation
ABUS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
ABUS
vs History
vs S&P 500
Ohlson's O-Score
27